eCyte, Inc.
PrivateLast Round
Series A
Extension
Jan 19, 2026
Total Funding Raised
$27.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
eCyte, Inc. is a biotechnology company that develops and commercializes scientific instruments for phenotype-based single-cell profiling and sorting.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eCyte, Inc. Comparables
Compare eCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hooke Instruments Ltd. | 84% | |
| Deepcell | 77% | |
| ThinkCyte | 76% |
eCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 19, 2026 | ||||
| Series A Extension | Apr 1, 2024 | ||||
| Series A | Dec 12, 2023 |
eCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Zhongke Yucheng Investment Management Co., Ltd. | Series A Extension |
| Shandong Caijin Investment Group | Series A Extension |
| Beiyang Haitang Venture Capital Fund | Series A |
| Hengxu Capital | Series A |
| 浙江浙商资本管理有限公司 | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
$14M round with participation from Qingdao Zhongke Yucheng and Shandong Caijin.
- Apr 1, 2024
Kweichow Moutai Co Ltd participated in the round.
eCyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about eCyte, Inc.'s valuation, stock price, and market status.
Is eCyte, Inc. a public or private company?
eCyte, Inc. is a private company.
What is the current stock price of eCyte, Inc.?
eCyte, Inc. is a private company with no public stock price. Caplight tracks eCyte, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is eCyte, Inc. worth (valuation)?
Valuation information for eCyte, Inc. is not publicly available.
Can I buy eCyte, Inc. stock?
eCyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was eCyte, Inc.'s last funding round?
eCyte, Inc.'s most recent funding round was Series A Extension on January 19, 2026.
Who are the main investors in eCyte, Inc.?
Key investors in eCyte, Inc. include Hengxu Capital.
Will eCyte, Inc. IPO soon?
No public IPO plans have been announced for eCyte, Inc..
How can I track eCyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eCyte, Inc.'s secondary market activity and sign up for updates.